Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment - findings from the Therapeutic Arthritis Research and Gastrointestinal Eve
Open Access
- 21 January 2008
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 27 (9), 838-845
- https://doi.org/10.1111/j.1365-2036.2008.03622.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2British Journal of Pharmacology, 2005
- Reduced incidence of upper gastrointestinal ulcer complications with the COX‐2 selective inhibitor, valdecoxibAlimentary Pharmacology & Therapeutics, 2004
- The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal eventsThe American Journal of Gastroenterology, 2003
- Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxenOsteoarthritis and Cartilage, 2002
- The hidden costs of arthritis treatment and the cost of new therapy—the burden of non‐steroidal anti‐inflammatory drug gastropathyRheumatology, 2002
- Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy TrialCurrent Medical Research and Opinion, 2002
- Reduced Incidence of Gastroduodenal Ulcers With Celecoxib, A Novel Cyclooxygenase-2 Inhibitor, Compared To Naproxen in Patients With ArthritisAmerican Journal Of Gastroenterology, 2001
- Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugsAmerican Journal Of Medicine, 2001
- Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled TrialMayo Clinic Proceedings, 1999
- Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1999